Physician Profile
Based in Abilene, TX, Anton M. Melnyk, MD, FACP is listed in the NPI registry under hematology & oncology. Anton is also listed as specializing in medical oncology. According to Medicare claims data, Anton cared for 2,998 Medicare patients across 156,049 services. The services billed most often include injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use), low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml, and injection, oxaliplatin, 0.5 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
1100 N 19TH ST SUITE 1A
Abilene, TX 79601
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
Blood disorders
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Most searched procedures
Biopsies & Diagnostics
Blood disorder care
Cancer Therapies
Cancer therapy
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
Supportive cancer care
Surgical & Vascular Access
Testing & Genetics
Vascular access care
156,049 services · 2,998 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,391 |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
491 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
389 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
251 |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
16,700 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
15,700 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
11,797 |
| Injection, dexamethasone sodium phosphate, 1 mg | Drug given | J1100 |
2,475 |
| Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Drug given | J1568 |
1,660 |
| Injection, ferric derisomaltose, 10 mg | Drug given | J1437 |
1,400 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Melnyk is a cancer specialist in Abilene, TX. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Dr. Melnyk is listed at 1100 N 19Th St Suite 1A, Abilene, TX 79601. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (325) 672-4368. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. Melnyk's National Provider Identifier is 1801834544. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Melnyk attended Other, graduating in 1988. This comes from the CMS National Downloadable File.
CMS public data
Dr. Melnyk has 38 years experience. Calculated from a graduation year of 1988, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Melnyk performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of chemotherapy into vein, 1 hour or less and infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Melnyk. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.